https://www.cantechletter.com/2026/10/whats-going-on-with-canadas-job-losses/Cantech Letteren2026-10-14T10:23:31-03:00What’s going on with Canada’s job losses? https://www.cantechletter.com/2026/10/this-biotech-stock-has-a-massive-upside-roth-says/Cantech Letteren2026-10-14T10:09:11-03:00This biotech stock has a massive upside, Roth says https://www.cantechletter.com/2026/10/red-hot-firan-technology-wins-another-price-target-raise/Cantech Letteren2026-10-13T19:17:59-03:00Red-hot Firan Technology wins another price target raise https://www.cantechletter.com/2026/10/buy-this-canadian-pot-stock-research-capital-says/Cantech Letteren2026-10-13T12:08:43-03:00Buy this Canadian pot stock, Research Capital says https://www.cantechletter.com/2026/10/amazon-is-still-a-reasonably-cheap-stock-this-investor-says/Cantech Letteren2026-10-13T11:29:07-03:00Amazon is still a “reasonably cheap” stock, this investor says https://www.cantechletter.com/2026/10/is-ameritrust-financial-technologies-undervalued/Cantech Letteren2026-10-13T11:14:45-03:00Is AmeriTrust Financial Technologies undervalued? https://www.cantechletter.com/2026/10/nvidia-is-still-a-cheap-stock-this-fund-manager-says-2/Cantech Letteren2026-10-13T10:28:32-03:00Nvidia is still a cheap stock, this fund manager says https://www.cantechletter.com/2026/10/is-ic-group-holdings-undervaled/Cantech Letteren2026-10-13T10:22:03-03:00Is IC Group Holdings undervaled? https://www.cantechletter.com/2026/10/tilray-why-this-analyst-just-cut-his-price-target/Cantech Letteren2026-10-12T12:00:36-03:00Tilray: why this analyst just cut his price target https://www.cantechletter.com/2026/10/why-national-bank-likes-anaergia-right-now/Cantech Letteren2026-10-12T11:54:33-03:00Why National Bank likes Anaergia right now https://www.cantechletter.com/2026/10/canadas-provinces-are-leading-investment-boom-rbc-says/Cantech Letteren2026-10-12T11:46:12-03:00Canada’s provinces are leading investment boom, RBC says https://www.cantechletter.com/2026/10/can-eupraxia-pharmaceuticals-stock-go-even-higher/Cantech Letteren2026-10-12T11:36:51-03:00Can Eupraxia Pharmaceuticals stock go even higher?